Effects of a novel free radical scavenger, MCI-186, on ischemic brain damage in the rat distal middle cerebral artery occlusion model

Journal of Pharmacology and Experimental Therapeutics

Volumn 281, Issue 2, 1997, Pages 921-927

  Kawai, Hiroshi ^a   Nakai, Hiroshi ^a   Suga, Misao ^a   Yuki, Satoshi ^a   Watanabe, Toshiaki ^a   Saito, Ken Ichi ^a  

^a MITSUBISHI CHEMICAL CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 OXO 3 (PHENYLHYDRAZONO)BUTANOIC ACID; DRUG METABOLITE; NORPHENAZONE; SCAVENGER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; BRAIN HOMOGENATE; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN PROTECTION; CONTROLLED STUDY; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PEROXIDATION; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIPYRINE; BRAIN; BRAIN ISCHEMIA; CEREBRAL ARTERIES; DISEASE MODELS, ANIMAL; FREE RADICAL SCAVENGERS; MALE; RATS; RATS, SPRAGUE-DAWLEY; REGIONAL BLOOD FLOW;

EID: 0030979729     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. ABE, K., YUKI, S. AND KOGURE, K.: Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavenger. Stroke 19: 480-485, 1988.
2. BACK, T., ZHAO, W. AND GINSBERG, M.D.: Three-dimensional image analysis of brain glucose metabolism-blood flow uncoupling and its electrophysiological correlates in the acute ischemic penumbra following middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 15: 566-577, 1995.
3. BEDERSON, J. B., PITTS, L. H., TSUJI, M., NISHIMUR, M. C., DAVIS, R. L. AND BARTOWSKI, H.: Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17: 472-476, 1986.
4. CAO, X., AND PHILLIS, J. W.: α-Phenyl-tert-butyl-nitrone reduces cortical infarct and edema in rats subjected to focal ischemia. Brain Res. 644: 267-272, 1994.
5. CHAN, H.: Antioxidant-dependent amelioration of brain injury: role of CuZn-superoxide dismutase. J. Neurotrauma 9: suppl. 2, S417-S423, 1992.
6. CHEN, S. T., HSU, C. Y., HOGAN, E. L., MARICQ, H. AND BALENTINE, J. D.: A model of focal ischemic stroke in the rat: reproducible extensive cortical infarction. Stroke 17: 738-743, 1986.
7. DAWSON, V. L., DAWSON, T. M., LONDON, E. D., BREDT, D. S., SNYDER, S. H.: Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. USA, 88: 6368-6371, 1991.
8. FLAMM, E. S., DEMOPOULOS, H. B., SELIGMAN, M. L., POSNER, R. G. AND RANSOHOFF, J.: Radicals in cerebral ischemia. Stroke 9: 445-447, 1978.
9. GARTHWAITE, J.: Glutamate, nitric oxide and cell-cell signaling in the nervous system. Trends Neurosci. 14: 60-67, 1991.
10. GINSBERG, M. D., GLOBUS, M. Y-T., MARTINEZ, E., MORIMOTO, T., LIN, B., SCHNIPPERING, H., ALONSO, O. F. AND BUSTO, R.: Oxygen radical and excitotoxic processes in brain ischemia and trauma. In Pharmacology of Cerebral ischemia, ed. by J. Krieglstein and S. H. Oberpichler, pp. 255-268, Wissenschaftliche Verlagsgesellschaft, Stuttgart, 1994.
11. HAKIM, A. M., HOGAN, M. J. AND CARPENTER, S.: Time course of cerebral blood flow and histological outcome after focal cerebral ischemia in rats. Stroke 23: 1138-1144, 1992.
12. IMAIZUMI, S., WOOLWORTH, V., FISHMAN, R. A. AND CHAN, P. H.: Liposome-entrapped superoxide dismutase reduces cerebral infarction in cerebral ischemia in rats. Stroke 21: 1321-1317, 1990.
13. ISAYAMA, K., PITTS, L. H. AND NISHIMURA, M. C.: Evaluation of 2,3,5-triphenyltetrazolium chloride staining to delineate rat brain infarcts. Stroke 22: 1394-1398, 1991.
14. KINOUCHI, H., EPSTEIN, C. J., MIZUI, T., CARLSON, E., CHEN, S. F. AND CHAN, P. H.: Attenuation of focal cerebral ischemia injury in transgenic mice overexpressing CuZn superoxide dismutase. Proc. Natl. Acad. Sci. U.S.A. 88: 11158-11162, 1991.
15. KITAGAWA, K., MATSUMOTO, M., ODA, T., NIINOBE, M., HATA, R., HANDA, N., FUKUNAGA, R., ISAKA, Y., KIMURA, K. AND KAMADA, T.: Free radical generation during brief period of cerebral ischemia may trigger delayed neuronal death. Neuroscience 35: 551-558, 1990.
16. LIPTON, S. A., CHOI, Y. B., PAN, Z. H., LEI, S. Z., CHEN, H. S. V., SUCHER, N. J., LOSCALZO, J., SINGLE, D. J. AND STAMLER, J. S.: A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364: 626-632, 1993.
17. MARKGRAF, C. G., KRAYDIEH, S., PRADO, R., WATSON, B. D., DIETRICH, W. D. AND GINSBERG, M. D.: Comparative histopathologic consequences of photothrombotic occlusion of the distal middle cerebral artery in Sprague-Dawley and wistar rat. Stroke 24: 286-293, 1993.
18. MATSUNO, H., UEMATSU, T., UMEMURA, K., TAKIGUCHI, Y., ASAI, Y., MURANAKA, Y. AND NAKASHIMA, M.: A simple and reproducible cerebral thrombosis model in rats induced by a photochemical reaction and the effect of a plasminogen-plasminogen activator chimera in this model. J. Pharmacol. Toxicol. Methods 29: 165-173, 1993.
19. MORIMOTO, T., GLOBUS, M. Y-T., BUSTO, R., MARTINEZ, E. AND GINSBERG, M. D.: Simultaneous measurement of salicylate hydroxylation and glutamate release in the penumbral cortex following transient middle cerebral artery occlusion in rats. J. Cereb. Blood Flow Metab. 16: 92-99, 1996.
20. MUROTA, S., MORITA, I. AND SUDA, N.: The control of vascular endothelial injury. Ann. NY Acad. Sci. 598: 182-187, 1990.
21. NISHI, H., WATANABE, T., SAKURAI, H., YUKI, S. AND ISHIBASHI, A.: Effect of MCI-186 on brain edema in rats. Stroke 20: 1236-1240, 1989.
22. OH, S. M. AND BETZ, A. L.: Interaction between free radicals and excitatory amino acids in the formation of ischemic brain edema in rats. Stroke 22: 915-921, 1991.
23. OISHI, T., ITOH, Y., NISHIBORI, M., WATANABE, T., NISHI, H. AND SAEKI, K.: Effect of MCI-186 on ischemia-induced changes in monoamine metabolism in rat brain. Stroke 20: 1557-1564, 1989.
24. 14C)antipyrine. Am. J. Physiol. 234: H59-H66, 1978.
25. SCHMIDLEY, J. W.: Free radicals in central nervous system ischemia. Stroke 21: 1086-1090, 1990.
26. SIESJO, B. K., AGARDH, C. D. AND BENGTSSON, F.: Free radicals and brain damage. Cerebrovasc. Brain Metab. Rev. 1: 165-211, 1989.
27. SIESJO, B. K.: Pathophysiology and treatment of focal cerebral ischemia, part II: mechanisms of damage and treatment. J. Neurosurg. 77: 337-354, 1992.
28. SYNDER, S. H.: Nitric oxide: First in a new class of neurotransmitters? Science 257: 464-466, 1992.
29. TAKAGI, K., GINSBERG, M. D., GLOBUS, M. Y-T., DIETRICH, W. D., MARTINEZ, E., KRAYDIEH, S. AND BUSTO, R.: Changes in amino acid neurotransmitters and cerebral blood flow in the ischemic penumbral region following middle cerebral artery occlusion in the rat: Correlation with histopathology. J. Cereb. Blood Flow Metab. 13: 575-585, 1993.
30. UMEMURA, K., WADA, T., UEMATSU, T. AND NAKASHIMA, M.: Evaluation of the combination of a tissue-type plasminogen activator, SUN9216, and a thromboxane A2 receptor antagonist, vapiprost, in a rat middle cerebral artery thrombosis model. Stroke 24: 1077-1082, 1993.
31. WATANABE, T., MORITA, I., NISHI, H., MUROTA, S.: Preventive effect of MCI-186 on 15-HPETE induced vascular endothelial cell injury in vitro. Prostaglandins Leuko Essent Fatty Acids 33: 81-87, 1988.
32. WATANABE, T., YUKI, S., EGAWA, M. AND NISHI, H.: Protective effects of MCI-186 on cerebral ischemia: Possible involvement of free radical scavenging and antioxidant actions. J. Pharmacol. Exp. Ther. 268: 1597-1604, 1994a.
33. WATANABE, T. AND EGAWA, M.: Effects of an antistroke agent MCI-186 on cerebral arachidonate cascade. J. Pharmacol. Exp. Ther. 271: 1624-1629, 1994b.
34. YAMAMOTO, Y., KUWAHARA, T., WATANABE, K. AND WATANABE, K.: Antioxidation activity of 3-Methyl-1-phenyl-pyrazolin-5-one. Redox Report 2: 333-338, 1996.
35. ZALESKA, M. M. AND FLOYD, R. A.: Regional lipid peroxidation in rat brain in vitro: Possible role of endogenous iron. Neurochem. Res. 10: 397-410, 1985.